Home

kull Dikteeri vältima c 169 tu marker Pimestav Leotatud hani

Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and  Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to  Brain Tumors
Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors

Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment  in the era of precision medicine | Modern Pathology
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology

Single-cell RNA sequencing reveals distinct tumor microenvironmental  patterns in lung adenocarcinoma | Oncogene
Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma | Oncogene

Cancers | Free Full-Text | Dissecting Tumor Growth: The Role of Cancer Stem  Cells in Drug Resistance and Recurrence
Cancers | Free Full-Text | Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence

Frontiers | Tumor-Induced Inflammatory Cytokines and the Emerging  Diagnostic Devices for Cancer Detection and Prognosis
Frontiers | Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis

The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes  resistance to anti-CTLA-4 therapy | Nature Communications
The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy | Nature Communications

Frontiers | C-Reactive Protein and Cancer—Diagnostic and Therapeutic  Insights
Frontiers | C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights

Receiver operating characteristic (ROC) curve analysis of the tumour markers  CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective  study. - Abstract - Europe PMC
Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. - Abstract - Europe PMC

Clinical Utility of Tumor Markers
Clinical Utility of Tumor Markers

Frontiers | Predictive and Prognostic Biomarkers for Lung Cancer Bone  Metastasis and Their Therapeutic Value
Frontiers | Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value

Cancers | Free Full-Text | CA125 and Ovarian Cancer: A Comprehensive Review
Cancers | Free Full-Text | CA125 and Ovarian Cancer: A Comprehensive Review

Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene  therapy using lipid nanoparticles: Molecular Therapy - Methods & Clinical  Development
Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles: Molecular Therapy - Methods & Clinical Development

Tumor-Promoting Ly-6G+ SiglecFhigh Cells Are Mature and Long-Lived  Neutrophils - ScienceDirect
Tumor-Promoting Ly-6G+ SiglecFhigh Cells Are Mature and Long-Lived Neutrophils - ScienceDirect

Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies: Trends  in Cancer
Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies: Trends in Cancer

Prostate cancer - Wikipedia
Prostate cancer - Wikipedia

Elevated tumor markers for monitoring tumor response to immunotherapy -  eClinicalMedicine
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine

High expression of PCOLCE gene indicate poor prognosis in patients and are  associated with immune infiltration in glioma | Scientific Reports
High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma | Scientific Reports

PDF) Spindle cell variant of medullary thyroid carcinoma: a  clinicopathologic study of four cases
PDF) Spindle cell variant of medullary thyroid carcinoma: a clinicopathologic study of four cases

Current advances in prognostic and diagnostic biomarkers for solid cancers:  Detection techniques and future challenges - ScienceDirect
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect

Laboratorija - BIOHEMIJSKI TUMOR-MARKERI BIOCHEMICAL TUMOUR-MARKERS *srb*  Tumorski markeri su specifični biomolekuli koje stvara organizam kao  metabolički ili imunološki odgovor zdrave ćelije na prisutnost maligne  ćelije ili ih produkuju same maligne ...
Laboratorija - BIOHEMIJSKI TUMOR-MARKERI BIOCHEMICAL TUMOUR-MARKERS *srb* Tumorski markeri su specifični biomolekuli koje stvara organizam kao metabolički ili imunološki odgovor zdrave ćelije na prisutnost maligne ćelije ili ih produkuju same maligne ...

Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and  M2-subtype TAM interaction to facilitate CRC metastasis: Molecular Therapy
Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis: Molecular Therapy

A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese  population | Nature Communications
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population | Nature Communications

Diagnostic value of four neuroendocrine markers in small cell  neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific  Reports
Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports

Frontiers | The Crosstalk Between Tumor Cells and the Immune  Microenvironment in Breast Cancer: Implications for Immunotherapy
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy